Result
€29,296 €29,296
Back in profit in 2025, after a loss of €35,630 in 2024.
EXTRAPHAR
Overview
Lifetime
4 annual accounts with figures on one time axispeak €30,884 (2025)
€30,884▲ €66,192
lowest -€35,630 (2024)
€29,296▲ €64,926
peak €6,568 (2023)
€234▲ €29,296
€10,024▼ 77.2%
Board1 name since 2022
1 directorHICINTUKA Marie Louella
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Gross margin from -€35,308 to €30,884Back to profit: €29,296Equity from -€29,062 to €234Debts from €43,936 to €10,024Cash from €3,475 to €5,127
Key points
from the 2025 annual accountsTurnover
≈ €160,000 estimated
The micro format states no turnover.
Debts
€10,024 98% of the balance sheet
Suppliers 55%Taxes and wages 45%
Liquidity
1.02 was 0.34 in 2024
Short-term debts fell from €43,936 to €10,024.
Filings
4 annual accounts 3 late
The 2024 accounts came latest: 36 days after the end of the period.
Position in the sector
€234
Less equity than 80% of companies in wholesale trade. Sector median €56,439 · 13,835 companies.
Checked score
67
Healthy
Financially stronger than 64% of micro companies in wholesale trade (NACE 46)
Probability in this band: 0.55% to 1.5%
Bankruptcy probability within 12 months
1.2% Low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.4% across 26,891 companies (NACE 46, micro).
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 2.6%
01-2025: 2.6%● unchanged vs 12-2024
02-2025: 2.5%▼ -0.1 percentage points vs 01-2025
03-2025: 2.5%● unchanged vs 02-2025
04-2025: 2.4%▼ -0.1 percentage points vs 03-2025
05-2025: 2.4%● unchanged vs 04-2025
06-2025: 2.4%● unchanged vs 05-2025
07-2025: 2.5%▲ +0.1 percentage points vs 06-2025
08-2025: 3.2%▲ +0.7 percentage points vs 07-2025
09-2025: 3.5%▲ +0.3 percentage points vs 08-2025highest value
10-2025: 2.2%▼ -1.3 percentage points vs 09-2025
11-2025: 2.2%● unchanged vs 10-2025
12-2025: 2.2%● unchanged vs 11-2025
01-2026: 2.2%● unchanged vs 12-2025
02-2026: 2.2%● unchanged vs 01-2026
03-2026: 1.9%▼ -0.3 percentage points vs 02-2026
04-2026: 1.8%▼ -0.1 percentage points vs 03-2026
05-2026: 1.9%▲ +0.1 percentage points vs 04-2026
06-2026: 1.9%● unchanged vs 05-2026
07-2026: 2.0%▲ +0.1 percentage points vs 06-2026
08-2026: 2.7%▲ +0.7 percentage points vs 07-2026
09-2026: 1.2%▼ -1.5 percentage points vs 08-2026lowest value
10-2026: 1.2%● unchanged vs 09-2026
11-2026: 1.2%● unchanged vs 10-2026
Financial strengthAverage
Score breakdown
raises risk
Last filed accounts filed 31 days late; 2 of the last 3 accounts late
Founded in 2022
lowers risk
Liquidity: current ratio 1.02, cash €5,127
Size: total assets €10,258
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro). It does better than 18% of them on solvency, 51% on liquidity, 95% on profitability and 93% on growth.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 2,157 companies had the same profile as EXTRAPHAR has now. Each dot stands for 6 companies, two years later.
94.1%
were still trading
2.8%
stopped another way
3.0%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of EXTRAPHAR itself: 1.2% within 12 months.
Test of the method
The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,157 companies, not a prediction for EXTRAPHAR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises risk
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 21% of 13805 sector peers (2025).
NBB · sector comparisonPosition among 13805 sector peers
Solvency
better than 21%
← weakest
strongest →
raises risk · 2025 accounts filed 31 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 4 filingsDeviation from the deadline
2025
31 days late
2024
36 days late
2023
6 days late
2022
1 day early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 4 accounts on average 18 days after the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 19 August (4 of the last 4 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0788510921
Incorporation
Founding capital of €2,500, 100 shares · Founder: HICINTUKA Marie Louella · Appointment: HICINTUKA Marie Louella (director) · published on 14-07-2022 · Gazette deed
First establishment
Calabriëlaan 38 - b9, Woluwe-Saint-Lambert
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| EXTRAPHAR Woluwe-Saint-Lambert | €10,258 | €30,884 | 2.3% | - |
| K-RO SOINS INFIRMIERS Ham-sur-Heure-Nalinnes | €29,464 | €27,577 | 12.1% | - |
| LINDEN API Ixelles | €12,520 | €8,810 | 82.9% | - |
| PowerMedic BeNeLux Keerbergen | €41,253 | €24,371 | 21.8% | - |
| GMC Anderlecht | €43,513 | €10,215 | 61.0% | - |
| MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES Jette | €68,309 | €20,502 | 85.5% | - |
| MAEYBO Boom | €58,761 | €29,051 | 85.5% | - |
These companies have the same main activity as EXTRAPHAR: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €12,500 and €68,300, founded between 2021 and 2024.
Official details
Source: KBO- Status
- Active since 12-07-2022Normal situation
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460and 5 others
- Establishment unit
- 2.333.290.6561200 Woluwe-Saint-Lambert, since 12-07-2022
- Financial year end
- 31 December
- Peppol
- Reachable since 18-03-2026
Insights on EXTRAPHAR
EXTRAPHAR files the micro format. That format states no turnover. The gross margin rose from -€9,984 in 2022 to €30,884 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
micro format, filed on 31-08-2026, 31 days late€30,884
▲ €66,192
€30,884
▲ €66,351
€29,296
▲ €64,926
€234
▲ €29,296
2.3%
▲ 197.7 percentage points
1.02
▲ 0.68
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €160,000. Estimated: probably between €99,000 and €320,000.
Balance sheet
balance sheet total €10,258 on 31-12-2025What the company ownsHow it is paid for
in euro
in euro
Position in the sector
2.3%
Higher than 21% of 13,805 companies in 2025.
1.02
Higher than 29% of 13,186 companies in 2025.
285.6%
Higher than 95% of 13,365 companies in 2025.
EXTRAPHAR
Middle half of the sector
80% of the sector
Micro accounts in wholesale trade (NACE 46)
Net result: top quarter · Equity: bottom quarter · Balance sheet total: bottom quarter · Working capital: middle half
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Balance sheet: assets | |||||
20/58 |
10,258 | 14,874 | 57,088 | 35,250 | |
21/28 |
- | - | - | 736 | |
22/27 |
- | - | - | 736 | |
23 |
- | - | - | 736 | |
29/58 |
10,258 | 14,874 | 57,088 | 34,515 | |
3 |
- | - | 30,300 | - | |
30/36 |
- | - | 30,300 | - | |
40/41 |
5,131 | 11,398 | 23,578 | 34,367 | |
40 |
5,131 | 11,398 | 23,578 | 34,367 | |
54/58 |
5,127 | 3,475 | 3,210 | 148 | |
| Balance sheet: equity and liabilities | |||||
10/49 |
10,258 | 14,874 | 57,088 | 35,250 | |
10/15 |
234 | -29,062 | 6,568 | -8,642 | |
10/11 |
2,500 | 2,500 | 2,500 | 2,500 | |
10 |
- | 2,500 | 2,500 | 2,500 | |
100 |
- | 2,500 | 2,500 | 2,500 | |
14 |
-2,266 | -31,562 | 4,068 | -11,142 | |
17/49 |
10,024 | 43,936 | 50,520 | 43,892 | |
42/48 |
10,024 | 43,936 | 50,520 | 43,892 | |
44 |
5,480 | 22,995 | 33,612 | 26,977 | |
440/4 |
5,480 | 22,995 | 33,612 | 26,977 | |
45 |
4,544 | 5,425 | 6,094 | 7,597 | |
450/3 |
4,544 | 4,589 | 2,954 | 7,597 | |
454/9 |
- | 836 | 3,140 | - | |
47/48 |
- | 15,516 | 10,815 | 9,318 | |
| Income statement | |||||
9900 |
30,884 | -35,308 | 18,101 | -9,984 | |
630 |
- | - | 2,391 | 736 | |
640/8 |
- | 159 | 428 | 417 | |
9901 |
30,884 | -35,467 | 15,281 | -11,136 | |
65/66B |
125 | 163 | 72 | 5 | |
65 |
125 | 163 | 72 | 5 | |
9903 |
30,758 | -35,630 | 15,209 | -11,142 | |
67/77 |
1,462 | - | - | - | |
9904 |
29,296 | -35,630 | 15,209 | -11,142 | |
9905 |
29,296 | -35,630 | 15,209 | -11,142 | |
| Appropriation of the result | |||||
9906 |
-2,266 | -31,562 | 4,068 | -11,142 | |
14P |
-31,562 | 4,068 | -11,142 | - | |
| Document | |||||
The notes to these accounts have 3 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 31-08-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank2025 annual accounts filed 31 days after the deadline. Filed on 31 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00493535.
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| - | - | 17,673 | -10,401 | ||
| - | - | 17,601 | -10,406 | ||
| - | - | 1,656 | 1,471 | ||
| 1,652 | 266 | 3,062 | - | ||
| 234 | -29,062 | 6,568 | -9,377 | ||
| 2.3% | -195.4% | 11.5% | -24.5% | ||
| 1.02 | 0.34 | 1.13 | 0.79 | ||
| 1.02 | 0.34 | 0.53 | 0.79 | ||
| - | - | 7.69 | - | ||
| - | - | 231.6% | - | ||
| 285.6% | -239.6% | 26.6% | -31.6% | ||
| - | - | over 100 | -2039.41 |
The equity ratios are withheld because equity of €234 is too small for a meaningful ratio.
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Tangible fixed assets | - | - | €1,656 | €1,471 |
| - | - | €2,391 | €736 |
Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)
Insights on EXTRAPHAR
The operating result for 2025 is a profit of €30,884, after a loss of €35,467 in 2024. It is the highest result since 2022.
Debt's share of the balance-sheet total is 97.7%.
Board & ownership
Board
1 director, since incorporationDirector (not named in the articles)
since 12-07-2022
term without a fixed end
listed in the 2025 annual accounts, filed on 31-08-2026
Mandates through the years
1 name, the dashed line is todayHICINTUKA Marie Louella
Director (not named in the articles)
Director (not named in the articles)
Board
Mandates as a list
- HICINTUKA Marie Louella
- Director (not named in the articles), from 12-07-2022 to date
Control
Capital
- Contribution
- €2,500
- Shares
- 100
- Contribution per share
- €25
- Equity per share
- €2.34 in 2025
- Source
- deed of 14-07-2022
Articles of association
deed of 14-07-2022 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
Shareholders
At incorporation
deed of 14-07-2022 ↗
- HICINTUKA Marie Louella 100 shares (100%) · in cash
Network & group
No group
EXTRAPHAR has no parent and no holdings in its annual accounts. HICINTUKA Marie Louella is the only director. EXTRAPHAR shares no director with another company.
Timeline
Timeline
11 events since 2022Filings
Financial
Establishments
20222023202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 31 days late
Registered in the Peppol Directory Reachable for e-invoices through 0208:0788510921
2025
Back to profit net €29,296 The net result is €29,296, after one loss-making year.
Liquidity triples current ratio 1.02 The current ratio rises from 0.34 to 1.02. Short-term debt falls from €43,936 to €10,024.
Annual accounts 2024 filed PDFmicro format · 36 days late
2024
Weakest financial year net -€35,630 The net result drops to -€35,630, the lowest from 2022 to 2025. It recovers the following year.
Annual accounts 2023 filed PDFmicro format · 6 days late
2023
Back to profit net €15,209 The net result is €15,209, after one loss-making year.
Annual accounts 2022 filed PDFmicro format · 1 day before the deadline
2022
IncorporationFounding capital of €2,500, 100 shares · Founder: HICINTUKA Marie Louella · Appointment: HICINTUKA Marie Louella (director) · published on 14-07-20226 points ▸
- Registered office clause, Avenue de Calabre, 38 - b9, 1200 Woluwe-Saint-Lambert
- Director appointment, HICINTUKA Marie Louella (director (not named in the articles))
- Power of attorney, Charles HUYLEBROUCK
- Founder, HICINTUKA Marie Louella
- Founding capital, €2,500, 100 shares
- 100 shares
- The deed holds 1 more point.
First establishment Calabriëlaan 38 - b9, Woluwe-Saint-Lambert
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
EXTRAPHAR was incorporated on 12 July 2022 as a private limited company by one natural person, with a starting capital of €2,500.12 Since 2022, HICINTUKA Marie Louella has served as director.3 Total assets fell from €35,250 in 2022 to €10,258 in 2025.4
Company details
Identity
- Enterprise number
- 0788.510.921
- VAT number
- BE 0788.510.921
- Peppol ID
- 0208:0788510921
- Other Peppol ID
- 9925:BE0788510921
- Legal form
- Private limited company
- Status
- Active, normal situation
- Founded
- 12-07-2022
- Financial year
- ends on 31 December
- Peppol
- Reachable since 18-03-2026Follow this company and you will hear the next morning if it leaves the Peppol register.
- Name
- EXTRAPHAR in French
- Entity type
- Legal entity
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 14-07-2022 (in French)
- Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
- “Région de Bruxelles-Capitale”deed of 14-07-2022 (in French)
Activities
NACEBEL 202546460
Wholesale of pharmaceutical and medical goods main activity
Codes under NACEBEL 2008
46460
Wholesale trade main activity
21201
Manufacture of basic pharmaceutical products and pharmaceutical preparations
46900
Non-specialised wholesale trade
47910
Retail trade
70220
Business consulting
82990
Other business support services
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “L’achat,la vente,l’importation,l’exportation,le commerce de gros et de détail,le commerce ambulant ainsi que les marchés publics de tous…”deed of 14-07-2022 (in French)
7 activities
- L’achat,la vente,l’importation,l’exportation,le commerce de gros et de détail,le commerce ambulant ainsi que les marchés publics de tous types de produits.
- Le commerce de détail et de gros de tous types de produits par correspondance ou par Internet (e-commerce)
- Le commerce sous toutes ses formes,dont l’e-commerce,le commerce par correspondance,en gros ou en détail,et notamment l’achat,la vente,tant en gros qu’au détail,l’importation,l’exportation,la fabrication,la conception,la distribution,la réalisation,la production,la diffusion et le commerce de tout produit ou élément se rapportant directement ou indirectement aux médicaments,à la pharmacie,au parapharmaceutique,à l’herboristerie,à la diététique,à l’hygiène,à la cosmétique,à la parfumerie,à la droguerie et de tout produit pouvant avoir la moindre incidence sur la santé de tout individu.
- L’exploitation,sous sa propre enseigne ou par voie de franchise ou licence de centres de fitness et/ou de bien-être,de piscines,de centres SPA,de hammams,de saunas,de jacuzzis,de bancs solaires,de salons de coiffure,de bancs solaires,de parfumeries,de centres d’esthétique,d’instituts de beauté,de centres de soins,de manucure,de pédicure,de la peau et d’épilation.
- Le commerce sous toutes ses formes,dont l’e-commerce,le commerce par correspondance,en gros ou en détail,et notamment l’achat,la vente,l’importation,la représentation,l’exportation,la fabrication,la transformation et de façon générale,le commerce et l’industrie de tous produits,matériels et articles de beauté,diététiques,sanitaires,de tous produits qui ont trait au bien-être,de parfumerie,de savonnerie,d'hygiène,de beauté,de cosmétiques,de maquillage,de diététique,d'articles cadeaux (trousses de toilette,de foulards,de cravates,de mouchoirs,…),de coutellerie,de maroquinerie,de petite maroquinerie,de bagagerie,d’articles de bijouterie,de dinanderie (bijoux de fantaisie,…),de lustrerie,d’horlogerie,de verrerie,de faïence,de porcelaine,de briquets,de stylos,de montres,d’articles pour fumeurs,d’articles de confection,de textile,de tout autre article de luxe et de tous les articles vendus en général en parfumerie,salons de coiffure,instituts de beauté,maisons de cadeaux,boutiques,maroquineries et en tous commerces ou établissements similaires.
- Ainsi que toutes activités de consultance,études,recherches,prospection,gestion,coordination,mise en œuvre et suivi dans le domaine du commerce et de l’industrie en général,notamment dans le domaine pharmaceutique,de l’agriculture,l’environnement,la construction,du transport,ainsi que la promotion de projets d’aide au développement,de projets d’investissements mobiliers et immobiliers et le montage de leur financement,sans que cette liste soit exhaustive
- La prestation de tout service dans le cadre de son objet
Registered office and establishments
1 establishment| Establishment | Since | Unit number |
|---|---|---|
| Calabriëlaan 38 - b9 registered office 1200 Woluwe-Saint-Lambert | 12-07-2022 | 2.333.290.656 |
Buildings and parcels at the address
- Ground area
- 2,115 m²
- Buildings
- 1,032 m²
- Volume, LiDAR
- 14,988 m³
- Tallest building
- 18.1 m
Buildings to scale, each on its own parcel
Parcels
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 21018A0172/00L000 | 2,115 m² | 1 · 1,032 m² | 18.1 m · 5 |